News
News
Michael Chang: “the U.S. Department of Justice Had Already Proven My Innocence”
Some media have reported on Dr. Michael Chang, the Chairman of OBI Pharma, Inc. (4174.TWO, hereinafter referred to as OBI) and the former president of …
News
Dr. Nathan Chen leaves OBI Pharma; Accepts New Role on Company’s Medical Advisory Board
OBI Pharma today announced that Dr. Nathan Chen has resigned his post as Chief Medical Officer for personal reasons, effective from August 10, 2016. Dr. …
News
OBI Pharma Presents Data for Novel Investigational OBI-822/OBI-821 in Patients with Metastatic Breast Cancer at the 2016 American Society of Clinical Oncology Annual Meeting
Results from Phase II/III Clinical Trials Show Improvement in Subset of Patients who Developed an Immune Response to Vaccination TAIPEI, TAIWAN, June 04, 2016 — …